Managing Generalised Myasthenia Gravis: A Tale of Two Targets
Managing Generalised Myasthenia Gravis: A Tale of Two Targets
Managing Generalised Myasthenia Gravis: A Tale of Two Targets
10 Aug 2022
•
1hr 2mins
Lost in Transmission: Addressing the Burden of Disease and Pathogenic Mechanisms of Generalized Myasthenia Gravis
Lost in Transmission: Addressing the Burden of Disease and Pathogenic Mechanisms of Generalized Myasthenia Gravis
Lost in Transmission: Addressing the Burden of Disease and Pathogenic Mechanisms of Generalized Myasthenia Gravis
1 Aug 2022
•
19mins
The Fear of Disappearing, the Fight to Stay Present': Understanding the Needs of Patients With Alzheimer's Disease
The Fear of Disappearing, the Fight to Stay Present': Understanding the Needs of Patients With Alzheimer's Disease
The Fear of Disappearing, the Fight to Stay Present': Understanding the Needs of Patients With Alzheimer's Disease
24 May 2022
•
15mins
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
24 May 2022
•
24mins
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
20 May 2022
•
32mins
Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
20 May 2022
•
40mins
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
6 May 2022
•
45mins
Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
28 Apr 2022
•
33mins
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
29 Mar 2022
•
17mins
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
29 Mar 2022
•
20mins